Abcam PLC (LSE:ABC) - Share price - Overview

Stock Report

Abcam PLC ABC

Last Price
GBX961.00

Day Change
-6.50|-0.67%

As of 17/11/2017
17:08:08 GMT | GBX
Minimum 15 Minutes Delay.

Last Close967.50p
Day Range953.50 - 973.50
Mkt Cap1.97Bil
52-Wk Range759.50 - 1,113.00
Yield %0.98
ISINGB00B6774699
Volume250,875
P/E41.96
P/S8.97
P/CF29.34

Share Price

Total Returns 17/11/2017

 Chg (%)  
More ...
Abcam PLC-4.41 
FTSE 100 TR GBP-1.44
 
Financials
201520162017
More ...
Income Statement
Turnover144.03171.67217.10
Operating Profit45.7346.3255.14
Net Profit37.3837.4342.36
Reported EPS18.5718.5320.74
Balance Sheet
Current Assets99.84118.86142.48
Non Current Assets149.42209.91218.23
Total Assets249.95329.56361.70
Current Liabilities21.0633.2932.60
Total Liabilities35.8468.3754.58
Total Equity214.10261.19307.12
Cash Flow
Operating Cash Flow48.8956.8076.44
Net Change in Cash1.5510.4015.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201880.6231.3837.0230.620.8312.401.29
201991.5035.1512.0127.342.2813.611.42

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
03/11/2017Transfer inMr. Alan Hirzel0.003450.00
03/11/2017Transfer inGavin Wood0.003450.00
21/09/2017SaleDr. Jonathan Milner1,016.803,107,03431,592,322.00
19/09/2017Transfer inDr. Jonathan Milner0.0095,0570.00

Company Profile

Abcam PLC is a biotechnology company engaged in developing antibodies for life science research and clinical communities. It works on regulatory molecules and proteins in biological pathways to treat diseases like cancer and immune deficiency disorders.

Sector

Biotechnology

Market Position

199 of 1833 Companies

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All Share

Outlook

(14/11/2017) "...the company is well positioned, with the right strategy and the right people to achieve its long term goals and continue to build value for all its stakeholders"

Next Event 08/12/2017

Dividend Payment
Ratios
CompSecMkt
More ...
PER (E)29.2713.6316.14
Div Yld (E)1.344.134.26
PEG (E)1.151.241.34
ROCE40.26180.3415.81
Op Mrgn25.87-8.42-9.53
EPS Grwth25.5112.8214.73
Dividends
PreviousLatest
More ...
Record Date17/03/1717/11/17
Ex-Div16/03/1716/11/17
Paid13/04/1708/12/17
Amnt2.837.36

Broker Sentiment

Strong Buy0
Buy2
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chairman (Interim)Lady Louise Patten of Wincanton
Chief Executive OfficerMr. Alan Hirzel
Chief Financial OfficerGavin Wood
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.